Gemtuzumab ozogamicin: one size does not fit all--the case for personalized therapy
- PMID: 21172885
- DOI: 10.1200/JCO.2010.32.2693
Gemtuzumab ozogamicin: one size does not fit all--the case for personalized therapy
Comment on
-
Identification of patients with acute myeloblastic leukemia who benefit from the addition of gemtuzumab ozogamicin: results of the MRC AML15 trial.J Clin Oncol. 2011 Feb 1;29(4):369-77. doi: 10.1200/JCO.2010.31.4310. Epub 2010 Dec 20. J Clin Oncol. 2011. PMID: 21172891 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
